Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Samsung Electronics | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
A prospective cohort of 150 individuals 22 years or older with a prior diagnosis or with a high likelihood of having moderate to severe OSA, screened using STOP-Bang and Epworth Sleepiness Scale questionnaires will be recruited and will utilize the Samsung Galaxy Watch technology to monitor sleep patterns, oxygen saturation, PPG, and heart rate variability amongst other physiologic parameters. All data will be collected over the course of two intervention nights in the sleep lab and at home for three nights.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Samsung Galaxy Watch technology | All participants screened will utilize the Samsung Galaxy Watch technology to monitor sleep patterns, oxygen saturation, PPG, and heart rate variability amongst other physiologic parameters. All data will be collected over the course of two intervention nights in the sleep lab and at home for three nights |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Samsung Galaxy Watch | Diagnostic Test | Samsung Galaxy Watch technology to monitor sleep patterns, oxygen saturation, PPG, and heart rate variability amongst other physiologic parameters. |
| Measure | Description | Time Frame |
|---|---|---|
| 4% Apnea Hypopnea Index (AHI) | Assessment of the 4% Apnea Hypopnea Index to determine the severity of sleep apnea | Day 1 (Visit 1), Day 5 (Visit 2) |
| Measure | Description | Time Frame |
|---|---|---|
| User acceptance and feasibility of Galaxy Watch technology | Evaluation of,
| Day 1 (Visit 1), Day 5 (Visit 2), At home monitoring (Day 2, 3 &4) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robson Capasso, MD | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42302984 | Derived | Alavi A, Costa E, Matsumoto MMS, Odenwald N, Kushida C, Bahmani A, Capasso R. Comprehensive Evaluation of Night-to-Night Variability in Polysomnography Metrics and Apnea-Hypopnea Index-Based Diagnostic Reclassification. Chest. 2026 Jun 16:S0012-3692(26)00782-8. doi: 10.1016/j.chest.2026.06.004. Online ahead of print. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided